Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C181590> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- NCIT_C181590 IAO_0000115 "A regimen consisting of carfilzomib, daratumumab and dexamethasone that can be used for the treatment of relapsed or refractory plasma cell (multiple) myeloma." @default.
- NCIT_C181590 NCIT_NHC0 "C181590" @default.
- NCIT_C181590 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C181590 NCIT_P108 "Carfilzomib/Daratumumab/Dexamethasone Regimen" @default.
- NCIT_C181590 NCIT_P208 "CL1664473" @default.
- NCIT_C181590 NCIT_R123 NCIT_C129821 @default.
- NCIT_C181590 NCIT_R123 NCIT_C129822 @default.
- NCIT_C181590 NCIT_R123 NCIT_C147908 @default.
- NCIT_C181590 NCIT_R123 NCIT_C155321 @default.
- NCIT_C181590 NCIT_R123 NCIT_C1636 @default.
- NCIT_C181590 NCIT_R123 NCIT_C163758 @default.
- NCIT_C181590 NCIT_R123 NCIT_C164008 @default.
- NCIT_C181590 NCIT_R123 NCIT_C1908 @default.
- NCIT_C181590 NCIT_R123 NCIT_C1909 @default.
- NCIT_C181590 NCIT_R123 NCIT_C20401 @default.
- NCIT_C181590 NCIT_R123 NCIT_C211 @default.
- NCIT_C181590 NCIT_R123 NCIT_C2160 @default.
- NCIT_C181590 NCIT_R123 NCIT_C2364 @default.
- NCIT_C181590 NCIT_R123 NCIT_C267 @default.
- NCIT_C181590 NCIT_R123 NCIT_C274 @default.
- NCIT_C181590 NCIT_R123 NCIT_C307 @default.
- NCIT_C181590 NCIT_R123 NCIT_C308 @default.
- NCIT_C181590 NCIT_R123 NCIT_C422 @default.
- NCIT_C181590 NCIT_R123 NCIT_C471 @default.
- NCIT_C181590 NCIT_R123 NCIT_C521 @default.
- NCIT_C181590 NCIT_R123 NCIT_C52196 @default.
- NCIT_C181590 NCIT_R123 NCIT_C548 @default.
- NCIT_C181590 NCIT_R123 NCIT_C574 @default.
- NCIT_C181590 NCIT_R123 NCIT_C74007 @default.
- NCIT_C181590 NCIT_R123 NCIT_C78272 @default.
- NCIT_C181590 normalizedInformationContent "100" @default.
- NCIT_C181590 referenceCount "1" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib-Daratumumab-Dexamethasone Regimen" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib-Daratumumab-Dexamethasone" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib-Dexamethasone Plus Daratumumab" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib-Dexamethasone-Daratumumab" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib/Daratumumab/Dexamethasone Regimen" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib/Daratumumab/Dexamethasone" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib/Dexamethasone Plus Daratumumab" @default.
- NCIT_C181590 hasExactSynonym "Carfilzomib/Dexamethasone/Daratumumab" @default.
- NCIT_C181590 hasExactSynonym "Daratumumab Plus KD Regimen" @default.
- NCIT_C181590 hasExactSynonym "Daratumumab-KD Regimen" @default.
- NCIT_C181590 hasExactSynonym "Darzalex-KD Regimen" @default.
- NCIT_C181590 hasExactSynonym "Kyprolis/Dexamethasone/Darzalex" @default.
- NCIT_C181590 inSubset NCIT_C160950 @default.
- NCIT_C181590 inSubset NCIT_C160952 @default.
- NCIT_C181590 type Class @default.
- NCIT_C181590 isDefinedBy ncit.owl @default.
- NCIT_C181590 label "Carfilzomib/Daratumumab/Dexamethasone Regimen" @default.
- NCIT_C181590 subClassOf B0d91a0fb0cf25e017f39829b75b7bd73 @default.
- NCIT_C181590 subClassOf B3355e12e30ab4880315fdbb48480ea9d @default.
- NCIT_C181590 subClassOf Bbfc6ec97fed50babdb53f8b5ae0533f8 @default.
- NCIT_C181590 subClassOf Bcb8f48b8e580be4489d58d518de28849 @default.
- NCIT_C181590 subClassOf Bd903ffc73d7b11b3a296adda29d02dc2 @default.
- NCIT_C181590 subClassOf Bf518d8f8efdcc4d83be6e804be92648e @default.
- NCIT_C181590 subClassOf NCIT_C12218 @default.
- NCIT_C181590 subClassOf NCIT_C159460 @default.
- NCIT_C181590 subClassOf NCIT_C181590 @default.
- NCIT_C181590 subClassOf NCIT_C186719 @default.
- NCIT_C181590 subClassOf NCIT_C186724 @default.
- NCIT_C181590 subClassOf NCIT_C62634 @default.
- NCIT_C181590 subClassOf NCIT_C63496 @default.